Ownership history in MARSHALL WACE, LLP · 11 quarters on record
This page tracks every 13F SEC filing in which MARSHALL WACE, LLP reported a position in STOKE THERAPEUTI (STOK). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | REDUCED | 768,287 | -1,532,267 | -66.6% | 0.02% | $18.1M | $23.50 |
| 2025 Q2 | ADDED | 2,300,554 | +168,771 | +7.9% | 0.03% | $26.1M | $11.35 |
| 2025 Q1 | ADDED | 2,131,783 | +1,180,351 | +124.1% | 0.02% | $14.2M | $6.65 |
| 2024 Q4 | REDUCED | 951,432 | -719,301 | -43.1% | 0.01% | $10.5M | $11.03 |
| 2024 Q3 | ADDED | 1,670,733 | +509,696 | +43.9% | 0.03% | $20.5M | $12.29 |
| 2024 Q2 | ADDED | 1,161,037 | +982,451 | +550.1% | 0.02% | $15.7M | $13.51 |
| 2024 Q1 | ADDED | 178,586 | +130,585 | +272.0% | 0.00% | $2.4M | $13.50 |
| 2023 Q3 | ADDED | 48,001 | +27,384 | +132.8% | 0.00% | $189K | $3.94 |
| 2022 Q3 | ADDED | 20,617 | +3,380 | +19.6% | 0.00% | $265K | $12.84 |
| 2022 Q1 | REDUCED | 17,237 | -25,164 | -59.3% | 0.00% | $362K | $21.05 |
As of 2025 Q4 — sorted by position size